| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jun AY et al. | Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. | 2014 | Invest New Drugs | pmid:23673814 |
| Kuroyanagi G et al. | Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. | 2014 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:24813642 |
| El-Hoss J et al. | Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). | 2014 | Bone | pmid:24269278 |
| Dumnicka P et al. | Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. | 2014 | Folia Med Cracov | pmid:25648306 |
| Nascimento MM et al. | Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. | 2014 | Braz. J. Med. Biol. Res. | pmid:25296363 |
| Inanc M et al. | Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. | 2014 | Med. Oncol. | pmid:24448976 |
| Canalis E et al. | Nemo-like kinase regulates postnatal skeletal homeostasis. | 2014 | J. Cell. Physiol. | pmid:24664870 |
| Zhou DA et al. | Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. | 2014 | BMC Musculoskelet Disord | pmid:25027542 |
| Rechenberg DK et al. | Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis. | 2014 | Cytokine | pmid:25022970 |
| Zanotti S et al. | Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. | 2014 | PLoS ONE | pmid:24489784 |